Traffic Lights - Latest Updates

Last updated: 05/09/2022

Other updates on this site
Drug Name Classification Clinical Indication Comments
APOMORPHINE Orange Parkinson's disease

Full SCA     Request form

BUDESONIDE/ FORMOTEROL FUMARATE DIHYDRATE INHALER (GoResp Digihaler®) (NEW) Grey Asthma & COPD

Not yet reviewed

BUSPIRONE Yellow Anxiety

Specialist psychiatrist initiation only.

DAPAGLIFLOZIN (Forxiga®) (UPDATED) Yellow Chronic Heart failure with reduced ejection fraction and preserved ejection fraction

In line with NICE TA679 and  NICE TA902

Dexcom ONE® Glucose Monitoring System (NEW) Yellow Diabetes glucose monitoring for those included on the LLRAPC position statement

Eligibility as per LLRAPC documents. Initial six months trial. Please see relevant documents for initiation and continuation.

ENOXAPARIN (Inhixa®) Yellow VTE prophylaxis for antenatal indications
FAVIPIRAVIR (Avigan®) (NEW) Red For treatment of Chronic Norovirus related to immunodeficiency
FERROUS FUMARATE Green Iron Deficiency Anaemia

Recommended ONCE DAILY dosage in adults as per NICE CKS and British Society of Gastroenterology

FERROUS SULPHATE Green Iron Deficiency Anaemia

Recommended ONCE DAILY dosage in adults as per NICE CKS and British Society of Gastroenterology

FreeStyle Libre 2® Sensor (UPDATED) Yellow Diabetes glucose monitoring for those included on the LLRAPC position statement.

Eligibility as per LLRAPC documents.  Initial  six month trial. Please see relevant documents for initiation and continuation. 

 

LIOTHYRONINE Red Treatment of depression where other therapies have failed

This should be under the advice of an NHS consultant psychiatrist. In line with NICE NG222

PROGESTERONE (Gepretix®) (NEW) Grey For adjunctive use with an oestrogen in post-menopausal women with an intact uterus, as hormone replacement therapy (HRT).

Not yet reviewed.

RIMEGEPANT (Vydura®) Grey Acute treatment of migraine with or without aura in adults

Not yet reviewed.

RIMEGEPANT (Vydura®) (NEW) Red For preventing migraine

In line with NICE TA906

Semaglutide (Wegovy®) (UPDATED) Do not prescribe Weight management in overweight and obese adults

Work is ongoing locally to plan for the implementation of NICE TA875. Semaglutide will only be available to patients that meet the eligibility criteria outlined by NICE and only through a specialist weight management service.

TACALCITOL (Curatoderm®) (NEW) Green Facial and Flexural psoriasis

To prescribe most cost effective pack size for repeated use.

Other Updates on this Website

Recent documents from LLR APC and TAS


About the Leicester, Leicestershire and Rutland Area Prescribing Committee

In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.

Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more